Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanism
Wade R. Gutierrez(Cancer Genetics (United States)), Rebecca D. Dodd(Cancer Genetics (United States))
Cited by 9
Related Papers
PRC2 loss drives MPNST metastasis and matrix remodeling
|JCI Insight|2022|21